procaterol has been researched along with Obstructive Lung Diseases in 2 studies
Procaterol: A long-acting beta-2-adrenergic receptor agonist.
Excerpt | Relevance | Reference |
---|---|---|
" The characteristics of the oral route are easy usage, precise dosage and assured effects." | 1.27 | Oral beta 2-selective adrenergic bronchodilators. ( Daniotti, S; Dottorini, M; Grassi, V; Schiassi, M; Tantucci, C, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grassi, V | 1 |
Daniotti, S | 1 |
Schiassi, M | 1 |
Dottorini, M | 1 |
Tantucci, C | 1 |
Baronti, A | 1 |
Lelli, M | 1 |
Manini, G | 1 |
Verdiani, P | 1 |
1 trial available for procaterol and Obstructive Lung Diseases
Article | Year |
---|---|
Procaterol metered aerosol in patients with chronic obstructive pulmonary disease.
Topics: Adrenergic beta-Agonists; Aerosols; Aged; Bronchodilator Agents; Drug Tolerance; Ethanolamines; Fema | 1987 |
1 other study available for procaterol and Obstructive Lung Diseases
Article | Year |
---|---|
Oral beta 2-selective adrenergic bronchodilators.
Topics: Administration, Oral; Adrenergic beta-Agonists; Aged; Asthma; Bronchodilator Agents; Child; Clenbute | 1986 |